<DOC>
	<DOCNO>NCT02347189</DOCNO>
	<brief_summary>Non-randomized , multi-center , prospective surveillance study investigate assess residual risk , confirm currently establish safety performance Melody TPV PB1016 .</brief_summary>
	<brief_title>Melody ( TM ) TPV PB1016 Surveillance Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>Patient eligible receive Melody TPV PB1016 per current Instructions Use ( IFU ) indication time study enrollment Patient ( patient 's legally authorize representative ) willing consent participate study commit completion followup requirement . Implantation aortic , tricuspid , mitral position Venous anatomy unable accommodate 22Fr size introducer sheath Obstruction central vein Clinical biological sign infection include active endocarditis History intravenous substance abuse Currently participate investigational drug device study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>